Rare Cancers Australia chief executive Christine Cockburn is understandably frustrated, using the term 'shame' to describe the recent dialogue between the Pharmaceutical Benefits Advisory Committee and industry. …
'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'
April 22, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News -
Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells
May 12, 2025 - -
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 - - Australian Biotech -
An already busy fixed ministerial bandwidth, just got much busier
May 12, 2025 - - Latest News -
Australia has been managing the risk of international reference pricing for most of this century
May 11, 2025 - - Latest News